Filing Flows

Filing Flows › Companies › cbdMD › Cash flow

cbdMD cash flow, quarter by quarter

Latest: Q3 FY26 · from the cash-flow statements filed with the SEC

Free cash flow−$460K in Q3 FY26 · −$2.4M over twelve months

Operating cash flow−$442K
Capital spending−$18K
Free cash flow−$460K
Cash conversion cycle91 days

Analysis

In Q3 FY26, cbdMD generated −$442K of operating cash flow and spent $18K on capital projects, leaving free cash flow of −$460K. That is $245K more than in Q3 FY25 (−$706K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$2.2M; the largest uses were operating cash flow ($2.2M), capital spending ($191K), other financing ($120K); besides operations, cash came from shares issued ($3.5M), other investing ($56K); the cash balance rose by $1.1M.

Operating cash flow was −$442K against net income of −$1.1M. The largest differences: depreciation & amortization +$259K, payables +$199K, receivables −$180K.

Its cash conversion cycle was 91 days (receivables 14 + inventory 129 − payables 52).

Free cash flow

cbdMD: free cash flow by quartercbdMD: free cash flow by quarter$157KQ4 FY24−$482KQ1 FY25−$205KQ2 FY25−$706KQ3 FY25−$244KQ4 FY25−$977KQ1 FY26−$728KQ2 FY26−$460KQ3 FY26
Operating cash flow less capital spending.
cbdMD: operating cash flow against capital spendingcbdMD: operating cash flow against capital spendingOperating cash flowCapital spending$167K$10KQ4 FY24−$318K$164KQ1 FY25−$189K$16KQ2 FY25−$704K$1KQ3 FY25−$241K$3KQ4 FY25−$812K$165KQ1 FY26−$722K$6KQ2 FY26−$442K$18KQ3 FY26
Latest (Q3 FY26): Operating cash flow −$442K, Capital spending $18K.

Capital allocation, year by year

cbdMD: where the cash came from (up) and went (down), by fiscal yearcbdMD: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingDividendsFY21: Operating cash flow −$14.1MFY21: Net borrowing −$97KFY21: Shares issued $30.9MFY21: Capital spending −$342KFY21: Dividends −$2.6M$30.9MFY21FY22: Operating cash flow −$15.0MFY22: Capital spending −$689KFY22FY23: Operating cash flow −$4.3MFY23: Shares issued $2.5MFY23: Capital spending −$298K$2.5MFY23FY24: Operating cash flow −$353KFY24: Shares issued $50KFY24: Capital spending −$190K$50KFY24FY25: Operating cash flow −$1.5MFY25: Shares issued $1.4MFY25: Capital spending −$184K$1.4MFY25
Over these 5 years operating cash flow totalled −$35.2M; the largest uses were operating cash flow ($35.2M) and dividends ($2.6M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$2.1M
Debtnone
Net cash$2.1M
Cash runway11 months

cbdMD is burning cash: its operations consume cash, a free cash flow of −$2.4M a year at the current rate against $2.1M of cash and investments: a runway of about 11 months before any new financing.

Where the cash came from and went

cbdMD: sources (+) and uses (−) of cash, Q3 FY26cbdMD: sources (+) and uses (−) of cash, Q3 FY26Cash drawn (+) / kept (−)$520KOperating cash flow−$442KOther financing−$58KCapital spending−$18KShares issued−$1K
cbdMD: sources (+) and uses (−) of cash, TTM to Q3 FY26cbdMD: sources (+) and uses (−) of cash, TTM to Q3 FY26Shares issued$3.5MOperating cash flow−$2.2MCash drawn (+) / kept (−)−$1.1MCapital spending−$191KOther financing−$120KOther investing$56K

From profit to cash

cbdMD: net income to operating cash flow, Q3 FY26cbdMD: net income to operating cash flow, Q3 FY26Net income−$1.1MDepreciation & amortization$259KReceivables−$180KInventory$43KPayables$199KDeferred revenue$19KPrepaid and other assets$160KOperating cash flow−$442K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 FY26141295291
Q2 FY26121284398
Q1 FY261413947106
Q4 FY251514557103
Q3 FY251415564105
Q2 FY25131356286
Q1 FY25111347373
Q4 FY24161266280

Every quarter

QuarterOperating cash flowCapital spendingDividendsShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 FY26−$442K−$18K—−$1K$520K−$460K
Q2 FY26−$722K−$6K—−$78K$750K−$728K
Q1 FY26−$812K−$165K—$2.1M−$1.1M−$977K
Q4 FY25−$241K−$3K—$1.4M−$1.2M−$244K
Q3 FY25−$704K−$1K——$706K−$706K
Q2 FY25−$189K−$16K−$1.0M—$205K−$205K
Q1 FY25−$318K−$164K−$1.0M—$482K−$482K
Q4 FY24$167K−$10K—$1−$57K$157K

cbdMD: income statement and cash flow

cbdMD, Q3 FY26: revenue $5.6M (+21% year over year), operating margin -20.4%. The chart follows the revenue to costs, profit and cash.

cbdMD: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.